Design
Review
Authors
Loading...
Pindolol expands beta-blocker options for hypertension via partial agonism; leaves open comparative effectiveness versus pure antagonists.
Pindolol is a beta-adrenoceptor antagonist with partial agonist activity approved for the treatment of systemic hypertension.
Koch‐Weser et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: